Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PR
1826
Permian Resources
PR
$17.4B
| $4.91M | ﹤0.01% |
733,396
-144,355
| -16% | -$787K |
|
1827
Ciena
CIEN
$47.5B
| $4.91M | ﹤0.01% |
95,548
-72,136
| -43% | -$4.01M |
|
1828
CALL
Duke Energy
DUK
$101B
| $4.88M | ﹤0.01% |
50,000
| – | – |
|
|
SPGS
1829
DELISTED
Simon Property Group Acquisition Holdings, Inc.
SPGS
| $4.88M | ﹤0.01% |
+499,997
| New | +$4.89M |
|
1830
PUT
Teva Pharmaceuticals
TEVA
$39.9B
| $4.87M | ﹤0.01% |
500,000
-450,000
| -47% | -$4.21M |
|
1831
Alarm.com
ALRM
$2.75B
| $4.86M | ﹤0.01% |
62,195
-45,084
| -42% | -$3.73M |
|
1832
Harley-Davidson
HOG
$2.61B
| $4.86M | ﹤0.01% |
132,728
+35,887
| +37% | +$1.45M |
|
1833
Atara Biotherapeutics
ATRA
$71.6M
| $4.85M | ﹤0.01% |
10,834
-6,340
| -37% | -$2.27M |
|
|
LAZR
1834
DELISTED
Luminar Technologies
LAZR
| $4.83M | ﹤0.01% |
20,652
+12,292
| +147% | +$3.25M |
|
1835
Vir Biotechnology
VIR
$1.46B
| $4.82M | ﹤0.01% |
110,814
+7,325
| +7% | +$317K |
|
1836
IPG Photonics
IPGP
$3.43B
| $4.8M | ﹤0.01% |
30,334
-105,018
| -78% | -$19.3M |
|
|
JBGS
1837
JBG SMITH
JBGS
$855M
| $4.79M | ﹤0.01% |
161,890
-42,846
| -21% | -$1.32M |
|
1838
Rapid7
RPD
$634M
| $4.78M | ﹤0.01% |
42,331
+12,950
| +44% | +$1.47M |
|
1839
NeoGenomics
NEO
$2.02B
| $4.76M | ﹤0.01% |
98,703
-9,072
| -8% | -$420K |
|
1840
Universal Health Services
UHS
$10.2B
| $4.76M | ﹤0.01% |
34,395
-12,211
| -26% | -$1.85M |
|
1841
PUT
Las Vegas Sands
LVS
$32B
| $4.76M | ﹤0.01% |
130,000
+100,000
| +333% | +$4.29M |
|
1842
First Trust Municipal High Income ETF
FMHI
$991M
| $4.75M | ﹤0.01% |
85,242
-575
| -0.7% | -$32.5K |
|
|
GSKY
1843
DELISTED
GreenSky, Inc. Class A Common Stock
GSKY
| $4.75M | ﹤0.01% |
424,773
+398,546
| +1,520% | +$3.13M |
|
1844
Axalta
AXTA
$7.5B
| $4.74M | ﹤0.01% |
162,385
-22,175
| -12% | -$663K |
|
1845
CALL
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$164M
| $4.73M | ﹤0.01% |
10,625
-10,625
| -50% | -$4.76M |
|
1846
Royalty Pharma
RPRX
$26.6B
| $4.72M | ﹤0.01% |
130,558
+12,913
| +11% | +$502K |
|
1847
First Trust Enhanced Short Maturity ETF
FTSM
$6.51B
| $4.72M | ﹤0.01% |
78,692
-20,211
| -20% | -$1.21M |
|
1848
Invesco Mortgage Capital
IVR
$764M
| $4.71M | ﹤0.01% |
149,374
+68,500
| +85% | +$2.23M |
|
|
PLAN
1849
DELISTED
Anaplan, Inc.
PLAN
| $4.7M | ﹤0.01% |
77,188
-210,462
| -73% | -$12.5M |
|
1850
National Health Investors
NHI
$3.8B
| $4.7M | ﹤0.01% |
87,767
-13,363
| -13% | -$835K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.